Age at Diagnosis and Postoperative Outcomes among Men Treated for Prostate Cancer in the U.S. Military Health System

Clinical Genitourinary Cancer · Published 2026-07-01 · DOI 10.1016/j.clgc.2026.102632

Authors (8)

Molly R. Oroho, Christian Dide-Agossou, Sean Q. Kern, Andrea A. Almeida, Sarah Darmon, Craig D. Shriver, Kangmin Zhu, Yvonne L. Eaglehouse

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Oroho, M., Dide-Agossou, C., Kern, S., et al. (2026). Age at Diagnosis and Postoperative Outcomes among Men Treated for Prostate Cancer in the U.S. Military Health System. Clinical Genitourinary Cancer. https://doi.org/10.1016/j.clgc.2026.102632

Related articles

• CT-Measured Psoas Area Predicts Urinary Incontinence Trajectories and Persistence After Robotic Prostatectomy: A 12-Month Analysis Using the 1-Hour Pad Test · Clinical Genitourinary Cancer · 2026 · Same journal
• Circulating Tumor DNA After Radical Cystectomy as a Marker of Minimal Residual Disease in Muscle-Invasive Bladder Cancer: A Literature Review · Clinical Genitourinary Cancer · 2026 · Same journal
• Delayed Progression-Free Survival Benefit of Belzutifan Versus Everolimus in LITESPARK-005: A Reconstructed Time-to-Event Reanalysis · Clinical Genitourinary Cancer · 2026 · Same journal
• Comparative and Critical Analysis of Immune-based Combinations for First-line Treatment of Metastatic Renal Cell Carcinoma · Clinical Genitourinary Cancer · 2026 · Same journal
• Evaluating Circulating DNA as a Prognostic Biomarker in Bladder Cancer Subtypes: A Preliminary Short Report · Clinical Genitourinary Cancer · 2026 · Same journal
• Oncologic Outcomes of Robot-Assisted Radical Cystectomy for Variant Histology Bladder Cancer: A Multi-institutional Propensity Score-Matched Analysis · Clinical Genitourinary Cancer · 2026 · Same journal
• Trophoblastic-Differentiated Urothelial Carcinoma: Real-World Sequencing and Clinical Implications · Clinical Genitourinary Cancer · 2026 · Same journal
• Teratoma-Specific Assay Design Enables Detection of Circulating Tumor DNA in Post-chemotherapy Residual Retroperitoneal Disease · Clinical Genitourinary Cancer · 2026 · Same journal
• Association Between Proto-Oncogene N-RAS Transcript Level and Overall Survival in Node-Negative Muscle-Invasive Bladder Cancer · Clinical Genitourinary Cancer · 2026 · Same journal
• Treatment Patterns and Survival Outcomes in a Real-World Cohort of Lutetium 177 Vipivotide Tetraxetan (LuPSMA)-Experienced Patients With Metastatic Castration-resistant Prostate Cancer (mCRPC) · Clinical Genitourinary Cancer · 2026 · Same journal